Month: November 2017
-
Sanofi Acquires Multiple Sclerosis Drug in $800M Deal
Drug maker Sanofi is licensing a drug candidate from Principia Biopharma Inc. designed to treat multiple sclerosis, an autoimmune condition affecting the brain and nervous system.
-
Psychology In Law: How Important Is An Online Presence For A Modern Law Firm?
Online resources are still a relatively new concept in the grand scheme of things, especially for a modern law firm.
-
Cancer Center, Analytics Company Partner on Precision Care
Memorial Sloan Kettering Cancer Center in New York is collaborating with health care analytics company Cota Inc. to offer more precise care strategies for patients.
-
Open-Source Model Devised to Value Medical Technologies
An initiative joining most major health care stakeholders is developing models to calculate the value of medical treatments, with a process described as open and transparent.
-
Virtual Reality Shown to Reduce Blood Draw Pain in Kids
Findings from a clinical trial show the use of virtual reality can prevent much of the pain and anxiety in children when drawing blood for tests.
-
Are You Ready To Do Business In The Digital World?
Here are a few things that you need to think about in order to make sure that you’re ready to do business in the digital world.
-
New Finance, Development Model for Pancreatic Disease
An organization is being formed to adopt performance-based financing and precision medicine to accelerate research and development on pancreatitis.
-
New Drug Shown to Reduce Depressive Behaviors
A new type of treatment for depression that works differently from most other anti-depressive drugs was shown in lab mice to reduce depression-like behaviors.
-
FDA Sets Genetic Health Test Review Process
The U.S. Food and Drug Administration is proposing new review requirements for genetic tests of health risks that providers market directly to consumers.
-
Plasma Infusions to Treat Alzheimer’s Shown Safe
Results from a small-scale clinical trial indicate treatments with plasma infusions from young donors are safe for patients and may improve functional abilities.